BackNLS Pharmaceutics Ltd - Warrants (25/09/2025) Overview

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Total Assets

Latest total assets for NLSPW: $4.3M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$4.34M
263.45% YoYΔ $3.14M vs prior year quarter

Peer average

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Total Assets History

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) vs. peers: Total Assets Comparison

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) (NLSPW) FAQ

NLS Pharmaceutics Ltd - Warrants (25/09/2025) (NLSPW) currently reports a total assets of $4.3M as of June 2025. That compares with $1.2M in the prior-year period — up 263.5% year over year. Use the charts on this page to explore NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s total assets history and peer comparisons.

NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s total assets increased from $1.2M to $4.3M — a 263.5% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NLS Pharmaceutics Ltd - Warrants (25/09/2025) reported $4.3M in total assets as of June 2025. That compares with $1.2M in the prior-year period — up 263.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $4.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NLS Pharmaceutics Ltd - Warrants (25/09/2025), and consider following NLSPW for alerts when major investors trade the stock.

NLS Pharmaceutics Ltd - Warrants (25/09/2025) is classified in the Healthcare sector. On total assets, it currently shows $4.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NLSPW with unrelated industries.